Daily non-political popular news in brief.

OHSU findings may improve how people with chronic heartburn, precancer of the esophagus are screened

12-04-2006 · EurekAlert!

Researchers in the Oregon Health & Science University Digestive Health Center are first to report that screening people with chronic heartburn or pre-cancer of the esophagus in an office setting using a "skinny scope" is as accurate, less expensive and less risky than a traditional sedated screening in a procedure room -- and patients prefer it. The findings are published online and in print in this month's issue of the American Journal of Gastroenterology.

Keywords: ohsu, findings, improve, people, chronic, heartburn, precancer, esophagus, screened, finding, esophagu

« Previous | Next »

Similar news on "OHSU findings may improve how people with chronic heartburn, precancer of the esophagus are screened":

Naked mole-rats bear chili pepper heat
01-28-2008 · EurekAlert!
Scientists have used gene therapy to restore sensation in naked mole-rats, strange rodents that lack a key neurotransmitter that causes prolonged pain perception in other mammals. The finding may lead to new analgesics for people with chronic pain who do not respond to current medication.
Similar news · Read more »
Cardio exercise benefits in male vs. female hearts
08-08-2007 · EurekAlert!
A new study examining chronic exercise in male and female mice finds that moderate long-term exercise provokes a sex-dependent cardiac adaptation that is different for females versus males. The findings may eventually help improve treatment strategies for women and men with heart disease.
Similar news · Read more »
Australian researchers develop treatment to treat obesity
11-06-2007 · EurekAlert!
A team of Australian researchers have developed a novel way to control the extreme weight loss, common in late-stage cancer, which often speeds death. The findings published today in Nature Medicine suggest it may soon be possible to prevent this condition, giving people the strength to survive treatment and improve their chances of recovery.
Similar news · Read more »
LIAI scientists make important finding on cytomegalovirus transmission
05-10-2007 · EurekAlert!
Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced -- and in some cases eliminated -- through the use of antibodies to enhance the disease-fighting power of the immune system. The research team's findings, based on controlled laboratory studies of mice, may also have implications for other chronic virus infections, such as hepatitis and HIV, the virus that causes AIDS.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Gene therapy offers new hope for treatment of peripheral neuropathy
05-31-2007 · EurekAlert!
Researchers from the University of Pittsburgh School of Medicine report that they have successfully used gene therapy to block the pain response in mice with neuropathic pain, a type of chronic pain in people for which there are few effective treatments. These findings are being presented at the 10th annual meeting of the American Society of Gene Therapy, being held May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.
Similar news · Read more »
Global community listens to TAU genetic researcher at EU Conference on Hearing Loss
07-09-2007 · EurekAlert!
Is hearing loss just one of those things that happens as we get older? Tel Aviv University is working towards finding a solution to deafness that will improve the quality of life for people everywhere. This week Prof. Karen Avraham represented a European consortium, EuroHear, at an international conference in France. With her Palestinian research colleague, Prof. Avraham is a leading figure in the field of hearing loss -- her landmark research in genetics has led to improved diagnostic tests which are currently being used today.
Similar news · Read more »
Cystic Fibrosis Foundation reports upward trend for key health outcomes
01-28-2008 · EurekAlert!
The Cystic Fibrosis Foundation reported today that key indicators of health for people with cystic fibrosis -- including lung function and nutritional status -- are rising nationwide across its accredited care center network. In fact, the outlook for people with CF continues to improve steadily each year -- and this progress is accelerating due to quality improvement programs spearheaded by the CF Foundation. The National Institutes of Health has recognized the Foundation's care center network as a model for delivering care for a chronic disease.
Similar news · Read more »
Researchers identify ovarian cancer biomarkers
03-07-2007 · EurekAlert!
Researchers have identified markers unique to the cells of blood vessels running through ovarian tumors. The finding, while preliminary, could one day improve screening, diagnosis and treatment for this disease.
Similar news · Read more »
How insulin-producing cells develop -- new finding could help fight against diabetes
05-17-2007 · EurekAlert!
A key aspect of how embryos create the cells which secrete insulin is revealed in a new study published tomorrow in the Journal of Biological Chemistry. The researchers hope that their findings will enable the development of new therapies for diabetes, a condition caused by insufficient levels of insulin. The research reveals that glucose plays a key role in enabling healthy beta cells, which secrete insulin, to develop in the pancreas of an embryo.
Similar news · Read more »